Literature DB >> 34024338

Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells.

Huishan Shi1, Jos P H Smits2, Ellen H van den Bogaard2, Matthew G Brewer3.   

Abstract

CRISPR/Cas9 technology is a powerful tool used to alter the genetic landscape of various hosts. This has been exemplified by its success in the transgenic animal world where it has been utilized to develop novel mouse lines modeling numerous disease states. The technology has helped to develop both in vitro and in vivo systems that simulate diseases within the fields of epithelial biology, skin cancer biology, dermatology, and beyond. Importantly, the delivery of the single-guide RNA/Cas9 editing complex to the host cell is key for its success. In this paper, we discuss the various methods that have been utilized as delivery techniques for CRISPR/Cas9 components, the benefits and pitfalls of each, and how successful they have been at genetically modifying epidermal cells. In addition, we acknowledge recent advances in the field of dermatology that have harnessed these methods to better understand epidermal biology, identify potential therapeutic targets, or serve as novel methods to treat disease states.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34024338      PMCID: PMC8224101          DOI: 10.1016/j.jid.2021.01.008

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   7.590


  22 in total

1.  Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes.

Authors:  Jiping Yue; Xuewen Gou; Yuanyuan Li; Barton Wicksteed; Xiaoyang Wu
Journal:  Cell Stem Cell       Date:  2017-08-03       Impact factor: 24.633

2.  CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Authors:  Daniela Benati; Francesca Miselli; Fabienne Cocchiarella; Clarissa Patrizi; Marta Carretero; Samantha Baldassarri; Virginia Ammendola; Cristina Has; Stefano Colloca; Marcela Del Rio; Fernando Larcher; Alessandra Recchia
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

3.  Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB Sensing.

Authors:  Gabriele Fenini; Serena Grossi; Emmanuel Contassot; Thomas Biedermann; Ernst Reichmann; Lars E French; Hans-Dietmar Beer
Journal:  J Invest Dermatol       Date:  2018-08-07       Impact factor: 8.551

Review 4.  Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.

Authors:  Joan Ramon Guitart; Jodi L Johnson; Wade W Chien
Journal:  J Invest Dermatol       Date:  2016-09       Impact factor: 8.551

5.  Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

Authors:  Xin Yu; Xiquan Liang; Huimin Xie; Shantanu Kumar; Namritha Ravinder; Jason Potter; Xavier de Mollerat du Jeu; Jonathan D Chesnut
Journal:  Biotechnol Lett       Date:  2016-02-18       Impact factor: 2.461

6.  Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome.

Authors:  Victoria Gálvez; Esteban Chacón-Solano; Jose Bonafont; Ángeles Mencía; Wei-Li Di; Rodolfo Murillas; Sara Llames; Asunción Vicente; Marcela Del Rio; Marta Carretero; Fernando Larcher
Journal:  Mol Ther Methods Clin Dev       Date:  2020-06-11       Impact factor: 6.698

Review 7.  Research Techniques Made Simple: CRISPR Genetic Screens.

Authors:  Auke B C Otten; Bryan K Sun
Journal:  J Invest Dermatol       Date:  2020-04       Impact factor: 8.551

Review 8.  In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  F1000Res       Date:  2017-12-20

9.  3D model of harlequin ichthyosis reveals inflammatory therapeutic targets.

Authors:  Florence Enjalbert; Priya Dewan; Matthew P Caley; Eleri M Jones; Mary A Morse; David P Kelsell; Anton J Enright; Edel A O'Toole
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

10.  Easy quantitative assessment of genome editing by sequence trace decomposition.

Authors:  Eva K Brinkman; Tao Chen; Mario Amendola; Bas van Steensel
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

View more
  1 in total

Review 1.  CRISPR-Cas9‒Based Genomic Engineering in Keratinocytes: From Technology to Application.

Authors:  Jos P H Smits; Luca D Meesters; Berber G W Maste; Huiqing Zhou; Patrick L J M Zeeuwen; Ellen H van den Bogaard
Journal:  JID Innov       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.